Crystal structures of Escherichia coli uridine phosphorylase in two native and three complexed forms reveal basis of substrate specificity, induced conformational changes and influence of potassium

被引:64
作者
Caradoc-Davies, TT [1 ]
Cutfield, SM [1 ]
Lamont, IL [1 ]
Cutfield, JF [1 ]
机构
[1] Univ Otago, Dept Biochem, Otago Sch Med Sci, Dunedin 9001, New Zealand
关键词
uridine phosphorylase; 5-fluorouracil; induced fit; specificity; potassium;
D O I
10.1016/j.jmb.2004.01.039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Uridine phosphorylase (UP) is a key enzyme in the pyrimidine salvage pathway that catalyses the reversible phosphorolysis of uridine to uracil and ribose I-phosphate. Inhibiting liver UP in humans raises blood uridine levels and produces a protective effect ("uridine rescue") against the toxicity of the chemotherapeutic agent 5-fluorouracil without reducing its antitumour activity. We have investigated UP-substrate interactions by determining the crystal structures of native Escherichia coli UP (two forms), and complexes with 5-fluorouracil/ribose I-phosphate, 2-deoxyuridine/ phosphate and thymidine /phosphate. These hexameric structures confirm the overall structural similarity of UP to E. coli purine nucleoside phosphorylase (PNP) whereby, in the presence of substrate, each displays a closed conformation resulting from a concerted movement that closes the active site cleft. However, in contrast to PNP where helix segmentation is the major conformational change between the open and closed forms, in UP more extensive changes are observed. In particular a swinging movement of a flap region consisting of residues 224-234 seals the active site. This overall change in conformation results in compression of the active site cleft. Gln166 and Arg168, part of an inserted segment not seen in PNP, are key residues in the uracil binding pocket and together with a tightly bound water molecule are seen to be involved in the substrate specificity of UP. Enzyme activity shows a twofold dependence on potassium ion concentration. The presence of a potassium ion at the monomer/monomer interface induces some local rearrangement, which results in dimer stabilisation. The conservation of key residues and interactions with substrate in the phosphate and ribose binding pockets suggest that ribooxocarbenium ion formation during catalysis of UP may be similar to that proposed for E. coli PNP. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:337 / 354
页数:18
相关论文
共 67 条
[1]   CRYSTAL-STRUCTURE OF THE HUMAN CELL-CYCLE PROTEIN CKSHS1 - SINGLE-DOMAIN FOLD WITH SIMILARITY TO KINASE N-LOBE DOMAIN [J].
ARVAI, AS ;
BOURNE, Y ;
HICKEY, MJ ;
TAINER, JA .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 249 (05) :835-842
[2]   Modulation of 5-fluorouracil host toxicity by 5-(benzyloxybenzyl)barbituric acid acyclonucleoside, a uridine phosphorylase inhibitor, and 2′,3′,5′-tri-O-acetyluridine, a prodrug of uridine [J].
Ashour, OM ;
Naguib, FNM ;
Panzica, RP ;
Al Safarjalani, ON ;
el Kouni, MH .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (03) :427-431
[3]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[4]   Purine nucleoside phosphorylase from Mycobacterium tuberculosis.: Analysis of inhibition by a transition-state analogue and dissection by parts [J].
Basso, LA ;
Santos, DS ;
Shi, WX ;
Furneaux, RH ;
Tyler, PC ;
Schramm, VL ;
Blanchard, JS .
BIOCHEMISTRY, 2001, 40 (28) :8196-8203
[5]   ROLE OF A BURIED ACID GROUP IN MECHANISM OF ACTION OF CHYMOTRYPSIN [J].
BLOW, DM ;
BIRKTOFT, JJ ;
HARTLEY, BS .
NATURE, 1969, 221 (5178) :337-&
[6]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[7]  
Burling FT, 2003, ACTA CRYSTALLOGR D, V59, P73, DOI [10.1107/S0907444902018929, 10.1107/s0907444902018929]
[8]   FORMYCIN-A AND FORMYCIN-B AND SOME ANALOGS - SELECTIVE INHIBITORS OF BACTERIAL (ESCHERICHIA-COLI) PURINE NUCLEOSIDE PHOSPHORYLASE [J].
BZOWSKA, A ;
KULIKOWSKA, E ;
SHUGAR, D .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1120 (03) :239-247
[9]  
Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34
[10]   Application and limitations of X-ray crystallographic data in structure-based ligand and drug design [J].
Davis, AM ;
Teague, SJ ;
Kleywegt, GJ .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (24) :2718-2736